Home › Funds › Royce & Associates › AMPH
Royce & Associates position in AMPH
AMPHASTAR PHARMACEUTICALS IN · Health Care
Latest position (Q2 2026)294.76K sh
Reported value held$5.95M
Portfolio Weight0.05%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 20.01K | $466.00K | New |
| Q1 2022 | 20.90K | $750.00K | Add |
| Q2 2022 | 13.55K | $471.00K | Reduce |
| Q1 2023 | 22.32K | $837 | New |
| Q2 2024 | 9.08K | $363.04K | New |
| Q3 2024 | 9.08K | $440.46K | Hold |
| Q4 2024 | 8.90K | $330.53K | Reduce |
| Q1 2025 | 247.86K | $7.19M | Add |
| Q2 2025 | 283.19K | $6.50M | Add |
| Q3 2025 | 366.32K | $9.76M | Add |
| Q4 2025 | 352.30K | $9.43M | Reduce |
| Q1 2026 | 406.18K | $7.96M | Add |
| Q2 2026 | 294.76K | $5.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMPH
- Vanguard Group 2.61M sh · $69.85M · Q4 2025
- Marshall Wace 1.07M sh · $21.52M · Q2 2026
- Geode Capital Management 969.84K sh · $19.58M · Q2 2026
- D. E. Shaw & Co 887.05K sh · $17.90M · Q2 2026
- Renaissance Technologies 525.10K sh · $10.60M · Q2 2026
- Goldman Sachs Group 505.36K sh · $10.20M · Q2 2026
- UBS Group AG 393.11K sh · $7.93M · Q2 2026
- Northern Trust Corp 370.99K sh · $7.49M · Q2 2026
- Charles Schwab Investment Management 310.18K sh · $6.26M · Q2 2026
- BlackRock Inc 6.83M sh · $6.19M · Q2 2026
- Two Sigma Investments 248.12K sh · $5.01M · Q2 2026